MeSH Review:
Tumor Burden
- Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. Moul, J.W., Sesterhenn, I.A., Connelly, R.R., Douglas, T., Srivastava, S., Mostofi, F.K., McLeod, D.G. JAMA (1995)
- Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy. Ravikumar, T., Rodrick, M., Steele, G., Marrazo, J., O'Dwyer, P., Dodson, T., King, V. J. Natl. Cancer Inst. (1985)
- Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden. Morgan, A.C., Crane, M.M., Rossen, R.D. J. Natl. Cancer Inst. (1984)
- Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. Tracey, K.J., Morgello, S., Koplin, B., Fahey, T.J., Fox, J., Aledo, A., Manogue, K.R., Cerami, A. J. Clin. Invest. (1990)
- Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Udd, L., Katajisto, P., Rossi, D.J., Lepistö, A., Lahesmaa, A.M., Ylikorkala, A., Järvinen, H.J., Ristimäki, A.P., Mäkelä, T.P. Gastroenterology (2004)
- Survival time in mice bearing TLX5 lymphoma subjected to rotational stress and chemotherapy with CCNU. Perissin, L., Rapozzi, V., Zorzet, S., Giraldi, T. Anticancer Res. (1997)
- Erythropoietin treatment of anemia associated with multiple myeloma. Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., Barnas, U. N. Engl. J. Med. (1990)
- Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey, T.A., Yang, N., Hay, A.R., McNeal, J.E., Freiha, F.S., Redwine, E. N. Engl. J. Med. (1987)
- Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Chen, C.M., Behringer, R.R. Genes Dev. (2004)
- Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Sato, K., Yamashita, N., Yamashita, N., Baba, M., Matsuyama, T. Immunity (2003)
- Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease. Dallas, S.L., Garrett, I.R., Oyajobi, B.O., Dallas, M.R., Boyce, B.F., Bauss, F., Radl, J., Mundy, G.R. Blood (1999)
- Reduction of tumor burden in a murine osteosarcoma following hyperthermia combined with cyclophosphamide. Hiramoto, R.N., Ghanta, V.K., Lilly, M.B. Cancer Res. (1984)
- Delayed cutaneous hypersensitivity to oxazolone in mice with tumors. Hemsworth, G.R., Wolff, J.S., Kraska, A.R., Jensen, K.E. Cancer Res. (1978)
- Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Silver, H.K., Karim, K.A., Archibald, E.L., Salinas, F.A. Cancer Res. (1979)
- Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Piazza, G.A., Alberts, D.S., Hixson, L.J., Paranka, N.S., Li, H., Finn, T., Bogert, C., Guillen, J.M., Brendel, K., Gross, P.H., Sperl, G., Ritchie, J., Burt, R.W., Ellsworth, L., Ahnen, D.J., Pamukcu, R. Cancer Res. (1997)
- Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. Szepeshazi, K., Schally, A.V., Halmos, G., Groot, K., Radulovic, S. J. Natl. Cancer Inst. (1992)
- Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. Soni, R., O'Reilly, T., Furet, P., Muller, L., Stephan, C., Zumstein-Mecker, S., Fretz, H., Fabbro, D., Chaudhuri, B. J. Natl. Cancer Inst. (2001)
- Gluconeogenesis in the tumor-influenced rat hepatocyte: importance of tumor burden, lactate, insulin, and glucagon. Inculet, R.I., Peacock, J.L., Gorschboth, C.M., Norton, J.A. J. Natl. Cancer Inst. (1987)
- Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Singh, A.V., Franke, A.A., Blackburn, G.L., Zhou, J.R. Cancer Res. (2006)
- Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Gleave, M.E., Hsieh, J.T., Wu, H.C., von Eschenbach, A.C., Chung, L.W. Cancer Res. (1992)
- Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Liu, P., Leong, T., Quam, L., Billadeau, D., Kay, N.E., Greipp, P., Kyle, R.A., Oken, M.M., Van Ness, B. Blood (1996)
- Improved outcome in adult B-cell acute lymphoblastic leukemia. Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmann, W., Löffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Büchner, T., Koch, P., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Fuhr, H.G., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gökbuget, N., Völkers, B., Messerer, D., Uberla, K. Blood (1996)
- Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Wysocka, M., Zaki, M.H., French, L.E., Chehimi, J., Shapiro, M., Everetts, S.E., McGinnis, K.S., Montaner, L., Rook, A.H. Blood (2002)
- Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Oyajobi, B.O., Franchin, G., Williams, P.J., Pulkrabek, D., Gupta, A., Munoz, S., Grubbs, B., Zhao, M., Chen, D., Sherry, B., Mundy, G.R. Blood (2003)
- Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Kumar, S., Witzig, T.E., Timm, M., Haug, J., Wellik, L., Kimlinger, T.K., Greipp, P.R., Rajkumar, S.V. Blood (2004)
- Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency. Medoff, G., Valeriote, F., Ryan, J., Tolen, S. J. Natl. Cancer Inst. (1977)
- Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens. Poulakos, L., Schenken, L.L., Hagemann, R.F., Burholt, D.R., Lesher, S. J. Natl. Cancer Inst. (1975)
- Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure. Bischoff, E.D., Heyman, R.A., Lamph, W.W. J. Natl. Cancer Inst. (1999)
- Enhancement of R3230AC rat mammary tumor growth and cellular differentiation by dibutyryl cyclic adenosine monophosphate. Klein, D.M., Loizzi, R.F. J. Natl. Cancer Inst. (1977)
- Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432. Okamoto, M., Oshikawa, T., Tano, T., Ohe, G., Furuichi, S., Nishikawa, H., Ahmed, S.U., Akashi, S., Miyake, K., Takeuchi, O., Akira, S., Moriya, Y., Matsubara, S., Ryoma, Y., Saito, M., Sato, M. J. Natl. Cancer Inst. (2003)
- Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Camerer, E., Qazi, A.A., Duong, D.N., Cornelissen, I., Advincula, R., Coughlin, S.R. Blood (2004)
- Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Winkelhake, J.L., Stampfl, S., Zimmerman, R.J. Cancer Res. (1987)
- 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel, H., Cleij, M.C., Collingridge, D.R., Hutchinson, O.C., Osman, S., He, Q., Luthra, S.K., Brady, F., Price, P.M., Aboagye, E.O. Cancer Res. (2003)
- Effect of five antineoplastic agents on tumor xenografts with different growth rates. Mattern, J., Wayss, K., Volm, M. J. Natl. Cancer Inst. (1984)
- Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75. Szende, B., Srkalovic, G., Groot, K., Lapis, K., Schally, A.V. J. Natl. Cancer Inst. (1990)
- All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., Chen, Y., Shen, Y., Wu, W., Tang, W., Waxman, S., De Thé, H., Wang, Z.Y., Chen, S.J., Chen, Z. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Reduced tumor load in peripheral blood after treatment with G-CSF and chemotherapy in children with tumors of the Ewing sarcoma family but not neuroblastoma. Burchill, S., Picton, S., Wheeldon, J., Kinsey, S., Lashford, L., Lewis, I. Blood (2003)
- Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Abe-Hashimoto, J., Kikuchi, T., Matsumoto, T., Nishii, Y., Ogata, E., Ikeda, K. Cancer Res. (1993)